July 5, 2016July 5, 2016

Lung Cancer Therapy Keytruda, Already OK’d for Different Cancers, Recommended for Approval in EU

Lung Cancer, News

Merck recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of the drug Keytruda (pembrolizumab), to be used ... Read more

October 29, 2015October 29, 2015

Merck’s NSCLC Drug Keytruda Outperforms Established Chemotherapy Drug

Lung Cancer, News

Merck recently announced topline data from the KEYNOTE-010 clinical trial assessing pembrolizumab as a treatment for patients with advanced non-small-cell lung cancer (NSCLC), determining that the study met its initial endpoint. Pembrolizumab (formerly MK-3475 and lambrolizumab, ... Read more